ARCHIVES

Clinical Trials: NCI Removes Brooklyn Site From PLCO Trials

This article is from The Cancer Letter archive.

Vol. 23 No. 41 | October 24, 1997

Download PDF Visit The Full Archive

Related Articles

NSABP Sees Groups To Join Breast Cancer Prevention Trial

September 27, 1991

Tivozanib Does Not Improve OS Compared to Sorafenib

February 22, 2013

FDA Approvals: Cobas HPV Test Approved For Primary Cervical Screening

April 25, 2014

Letters: NCI Mammography Statement Recognizes Patient Autonomy

February 25, 1994

No Recision Seen, New Money To Low In Mid-March

February 20, 1976

NTP Board Approves Concept Of Human Cell Assay For Genetic Toxicity

March 25, 1983